Anika Therapeutics (ANIK) Return on Sales: 2011-2025
Historic Return on Sales for Anika Therapeutics (ANIK) over the last 14 years, with Sep 2025 value amounting to -0.17%.
- Anika Therapeutics' Return on Sales fell 3.00% to -0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.17%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of -0.40% for FY2024, which is 26.00% up from last year.
- According to the latest figures from Q3 2025, Anika Therapeutics' Return on Sales is -0.17%, which was up 60.03% from -0.42% recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Return on Sales registered a high of 0.10% during Q2 2024, and its lowest value of -0.42% during Q2 2025.
- Over the past 3 years, Anika Therapeutics' median Return on Sales value was -0.08% (recorded in 2023), while the average stood at -0.15%.
- In the last 5 years, Anika Therapeutics' Return on Sales grew by 23bps in 2021 and then plummeted by 51bps in 2025.
- Anika Therapeutics' Return on Sales (Quarterly) stood at 0.05% in 2021, then fell by 4bps to 0.00% in 2022, then declined by 3bps to -0.03% in 2023, then plummeted by 37bps to -0.40% in 2024, then decreased by 3bps to -0.17% in 2025.
- Its Return on Sales stands at -0.17% for Q3 2025, versus -0.42% for Q2 2025 and -0.39% for Q1 2025.